Radiomics from PET/CT imaging was found to be similarly strongly predictive as CT but outperformed PET in PD-L1 expression level prediction for 399 stage I-IV non-small cell lung cancer (NSCLC) patients (AUC > 0.8, internal validation) [99]. This evidence concerns the gene CD274 and non-small cell lung carcinoma.